CASP1 and neoplasm: revealed that sorafenib-treated MΦ presented caspase-1-activated pyroptosis, contributing to the release of numerous proinflammatory cytokines and the proliferation of NK cells, ultimately suppressing the development and metastasis of tumor cells (59).